Insilico Medicine
03696.HK
Harnessing deep learning to accelerate pharmaceutical development.
Harnessing deep learning to accelerate pharmaceutical development.
Investment Team
Sector
Life SciencesCategory
AITherapeutics
Status
PublicLocation
Hong KongInitial Investment
2019
Insilico specializes in artificial intelligence for drug discovery, biomarker development and aging research.